Abstract
BackgroundTo investigate the safety and efficacy of perventricular device closure of perimembranous VSD (pmVSD).MethodsPubMed and Scopus were searched for studies in English focusing on perventricular device closure of pmVSD published up to the end of March 2019. We used a random-effects model to obtain pooled estimates of the success and complication rates.ResultsA total of 15 publications comprising 1368 patients with pmVSD were included. The median follow-up duration was 2 months to 5 years, with a mean patient age ranging from 2 months to 56 years. The pooled success rate was 0.95 (I2 = 86.2%, P = 0.000). The pooled rate of postoperative residual shunting was 0.02 (95% CI: 0.01–0.03, I2 = 87.3%, P < 0.001). The pooled rate of residual shunting in the follow-up period was 0.001 (95% CI:-0.001–0.002, I2 = 30.5%, P = 0.126). The pooled estimated rate of severe complications was 0.074 (95% CI: 0.046–0.102, I2 = 30.5%, P = 0.126). The pooled incidence of complete atrioventricular block (cAVB) was 0.002 (95% CI: 0.000–0.005, I2 = 0.0%, P = 0.577).ConclusionsPerventricular device closure may be an alternative to conventional surgical repair in selected patients with pmVSD. The success rate was stable regarding the publication year and sample size and suggested both the short learning curve of this technology and its potential for wide application. The incidence of severe arrhythmia, especially cAVB, was low. These good results may be limited by the number of enrolled patients, and a more detailed and larger sample is required for further analysis.
Highlights
Ventricular septal defect (VSD) is one of the most common congenital hearts defects (CHDs), accounting for 20% of all forms of congenital cardiac malformations, and 80% of VSD cases are perimembranous VSD [1, 2]
Conventional surgical repair of VSD under cardiopulmonary bypass (CPB) is the gold standard treatment [3]. This approach cannot avoid the potential for CPB-related complications or complete atrioventricular block
This study aimed to obtain pooled estimates of the success and morbidity rates after perventricular device closure of perimembranous VSD (pmVSD) based on a meta-analysis of the current literature
Summary
Ventricular septal defect (VSD) is one of the most common congenital hearts defects (CHDs), accounting for 20% of all forms of congenital cardiac malformations, and 80% of VSD cases are perimembranous VSD [1, 2]. Conventional surgical repair of VSD under cardiopulmonary bypass (CPB) is the gold standard treatment [3]. This approach cannot avoid the potential for CPB-related complications or complete atrioventricular block (cAVB), Hong et al Journal of Cardiothoracic Surgery (2019) 14:119 could guide further research on and development of occluders to achieve better outcomes with fewer complications. To investigate the safety and efficacy of perventricular device closure of perimembranous VSD (pmVSD)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have